265 related articles for article (PubMed ID: 23584313)
21. High dose transdermal buprenorphine for moderate to severe pain in spanish pain centres--a retrospective multicenter safety and efficacy study.
Barutell C; Camba A; González-Escalada JR; Rodríguez M;
Pain Pract; 2008; 8(5):355-61. PubMed ID: 18662364
[TBL] [Abstract][Full Text] [Related]
22. Low-dose 7-day transdermal buprenorphine in daily clinical practice - perceptions of elderly patients with moderate non-malignant chronic pain.
Uberall MA; Müller-Schwefe GH
Curr Med Res Opin; 2012 Oct; 28(10):1585-95. PubMed ID: 22978772
[TBL] [Abstract][Full Text] [Related]
23. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
Sittl R; Nuijten M; Nautrup BP
Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
[TBL] [Abstract][Full Text] [Related]
24. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of full agonist opioids in patients stabilized on buprenorphine undergoing major surgery: a case series.
Kornfeld H; Manfredi L
Am J Ther; 2010; 17(5):523-8. PubMed ID: 19918165
[TBL] [Abstract][Full Text] [Related]
26. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
Sittl R; Likar R; Nautrup BP
Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
[TBL] [Abstract][Full Text] [Related]
27. Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model.
Pade PA; Cardon KE; Hoffman RM; Geppert CM
J Subst Abuse Treat; 2012 Dec; 43(4):446-50. PubMed ID: 22980449
[TBL] [Abstract][Full Text] [Related]
28. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
29. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Sorge J; Sittl R
Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
[TBL] [Abstract][Full Text] [Related]
30. Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group.
Apolone G; Corli O; Negri E; Mangano S; Montanari M; Greco MT; ; Apolone G; Bertetto O; Caraceni A; Corli O; De Conno F; Labianca R; Maltoni M; Nicora Maria F; Torri V; Zucco F
Clin J Pain; 2009 Oct; 25(8):671-82. PubMed ID: 19920716
[TBL] [Abstract][Full Text] [Related]
31. [Opioid therapy for chronic noncancer pain: retrospective analysis of patients hospitalized for withdrawal].
Faure D; Giniès P; Eiden C; Portet L; Peyrière H
Therapie; 2013; 68(6):385-92. PubMed ID: 24356190
[TBL] [Abstract][Full Text] [Related]
32. [Buprenorphine transdermal patch (Norspan tape)].
Hamaguchi S; Ikeda T
Masui; 2013 Jul; 62(7):799-807. PubMed ID: 23905402
[TBL] [Abstract][Full Text] [Related]
33. Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial.
Brema F; Pastorino G; Martini MC; Gottlieb A; Luzzani M; Libretti A; Saccà L; Cigolari S
Int J Clin Pharmacol Res; 1996; 16(4-5):109-16. PubMed ID: 9172009
[TBL] [Abstract][Full Text] [Related]
34. Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain.
Miller K; Yarlas A; Wen W; Dain B; Lynch SY; Brennan MJ; Ripa SR
Expert Opin Pharmacother; 2013 Feb; 14(3):269-77. PubMed ID: 23374027
[TBL] [Abstract][Full Text] [Related]
35. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
36. Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Gálvez R; Schäfer M; Hans G; Falke D; Steigerwald I
Adv Ther; 2013 Mar; 30(3):229-59. PubMed ID: 23475406
[TBL] [Abstract][Full Text] [Related]
37. Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine.
Mark TL; Dilonardo J; Vandivort R; Miller K
J Subst Abuse Treat; 2013; 44(5):481-7. PubMed ID: 23265445
[TBL] [Abstract][Full Text] [Related]
38. Transdermal buprenorphine (Butrans) for chronic pain.
Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936
[TBL] [Abstract][Full Text] [Related]
39. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
Mitra F; Chowdhury S; Shelley M; Williams G
Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
[TBL] [Abstract][Full Text] [Related]
40. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]